About 1,170 results

ALLMedicine™ Solitary Fibrous Tumor Center

Research & Reviews  448 results

68Ga-DOTATOC PET/CT Imaging of a Muscular Solitary Fibrous Tumor.
Clinical Nuclear Medicine; Richard C, Cros J et. al.

Mar 1st, 2023 - A 73-year-old woman was referred for 68Ga-DOTATOC PET/CT staging of a grade 2 pancreatic neuroendocrine tumor, which showed the primary pancreatic tumor, liver metastases, one left pleural metastasis, and high uptake in a mass of the right triceps...

A case of dedifferentiated meningeal solitary fibrous tumor.
Journal of Neuropathology and Experimental Neurology; Persons JE, Eschbacher KL

Feb 8th, 2023 - A case of dedifferentiated meningeal solitary fibrous tumor.|2023|Persons JE,Eschbacher KL,|

GAB1::ABL1 fusions define a distinctive soft tissue neoplasm, with variable perineurial...
Genes, Chromosomes & Cancer; Agaimy A, Perret R et. al.

Feb 7th, 2023 - Although well known as a fusion partner in hematological malignancies, fusion genes involving the ABL proto-oncogene 1 (ABL1), mapping to chromosomal region 9q34.12, have only been anecdotally reported in five soft tissue tumors. These neoplasms h...

68 Ga-PSMA-Avid Intranasal Solitary Fibrous Tumor.
Clinical Nuclear Medicine; Riaz S, Priftakis D et. al.

Feb 3rd, 2023 - The utility of molecular imaging in solitary fibrous tumors has not been fully established. We present a rare case of recurrent intranasal solitary fibrous tumor incidentally localized on 68 Ga-PSMA PET/CT scan, which turned out to be metabolicall...

Cervical Intramedullary Solitary Fibrous Tumor.
The Canadian Journal of Neurological Sciences. Le Journal... Attia EM, Sharma S et. al.

Jan 21st, 2023 - Cervical Intramedullary Solitary Fibrous Tumor.|2023|Attia EM,Sharma S,Woodley-Cook J,Spears J,Munoz DG,|

see more →

Clinicaltrials.gov  6 results

Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma

Feb 1st, 2022 - To estimate the sample size for stratum 1 (SFT), a Simon's optimal 2-stage phase II design has been used, having considered the published response rate based on Choi criteria in SFT patients which correspond to 40% in monotherapy. For a design wit...

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

Nov 18th, 2021 - Cohorts 1-6: COHORT 1 - Dedifferentiated Chondrosarcoma (DDCS): For DDCS sample size is obtained for the primary endpoint of 6-month progression-free survival rate, estimated accrual 24 months. A 6-m PFSR of 40% will be considered not promising wh...

Eribulin in Advanced Solitary Fibrous Tumor

Nov 1st, 2021 - This is an Italian, non randomized, open label, multi center, investigator-initiated, Phase II, clinical study to explore the activity of eribulin in a population of patients with progressive, advanced (i.e. locally advanced or metastatic), molecu...

Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor

Nov 1st, 2021 - Patients with solitary fibrous tumor will be randomized to receive 6 cycles of trabectedin or doxorubicin plus dacarbazine. In case of progression or unacceptable toxicity while under the experimental treatment prior to the completion of the 6 cyc...

Phase II Study on Axitinib in Advanced Solitary Fibrous Tumor

Sep 28th, 2021 - This is an investigator initiated, open label, prospective, non-randomized, phase II trial aimed at evaluating the activity of Axitinib in progressive VEGFR2 and/or PDGFRB positive advanced Solitary Fibrous Tumor (SFT) patients. Patients with a do...

see more →

News  8 results

Combination of Cixutumumab and Temsirolimus Demonstrates Improved Progression-Free and Encouraging Overall Survival for Bone and Soft Tissue Sarcoma

Oct 6th, 2021 - Gary Schwartz, MD Chief, Melanoma and Sarcoma Service Memorial Sloan-Kettering Cancer Center The first and largest national clinical study to evaluate the safety and efficacy of an IGF-1R antibody (cixutumumab) and an mTOR inhibitor (temsiro...

Targeted Therapies for Adult STS

Apr 2nd, 2021 - Transcript: William D. Tap, MD: What about the other FDA-approved drug for general soft tissue sarcomas, except for liposarcomas, such as Votrient (pazopanib)? What role does that play? I also want to bring us to more of the targeted discussio...

Modern Therapies Expand Options for Soft-Tissue Sarcomas

Dec 5th, 2020 - William D. Tap, MD Although soft-tissue sarcoma (STS) is seldom diagnosed in adults, the development of several new therapies in recent years for patients with rare subtypes is energizing leaders in the field and underscoring the need for a multi...

Primary renal synovial sarcoma – a diagnostic dilemma
Yellala et al

Oct 29th, 2018 - Soft tissue sarcomas are rare mesenchymal tumors that comprise 1% of all malignancies. Synovial sarcoma accounts for 5% to 10% of adult soft tissue sarcomas and usually occurs in close association with joint capsules, tendon sheaths, and bursa in.

Primary renal synovial sarcoma – a diagnostic dilemma
Yellala et al

Oct 29th, 2018 - Soft tissue sarcomas are rare mesenchymal tumors that comprise 1% of all malignancies. Synovial sarcoma accounts for 5% to 10% of adult soft tissue sarcomas and usually occurs in close association with joint capsules, tendon sheaths, and bursa in.

see more →

Patient Education  6 results see all →